Innovative Product Portfolio Biogennix specializes in advanced osteobiologic products such as bone grafts, fusion kits, and surgical matrices, demonstrating a robust and diverse product line that appeals to orthopedic and spine surgery markets seeking cutting-edge regeneration solutions.

Recent Market Launches The company's recent launches of products like DirectCell and Agilon Surgical Matrix highlight ongoing innovation and market expansion efforts, presenting opportunities to engage with surgeons and hospitals adopting new bone regeneration technologies.

Growth Potential With annual revenues estimated between 1 million and 10 million and a focused niche, Biogennix offers a promising entry point for tailored partnerships, especially targeting hospitals and surgical centers seeking effective osteobiologics.

Community & COVID Response Biogennix's development of clinical-strength hand sanitizer in partnership with local providers signals a proactive approach to community health, opening avenues for supply chain collaborations and healthcare safety product sales.

Strategic Location and Expertise Headquartered in Irvine, California’s Technology Coast with a team of leading scientists, Biogennix leverages regional innovation clusters and scientific expertise to strengthen credibility and foster partnerships within the medical device and biotech sectors.